SRSF6 and colonic neoplasm: SRSF6 was reported to be significantly amplified in breast, lung, ovarian, and colon cancers, and promotes oncogenic splicing and further controls cell proliferation, metastasis, and drug resistance (Adhikary & Eilers, 2005; She et al., 2021).